Workflow
Medical Devices
icon
Search documents
Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance
Prnewswire· 2025-10-15 11:30
Accessibility StatementSkip Navigation ABBOTT PARK, Ill., Oct. 15, 2025 Â /PRNewswire/ --Â Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2025. "Our third-quarter results demonstrate our ability to deliver consistent, high-quality performance," said Robert B. Ford, chairman and chief executive officer, Abbott. "Our differentiated product pipeline continues to power our performance and positions Abbott to deliver durable long-term value to our shareholders." THIRD- ...
Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025
Globenewswire· 2025-10-15 11:00
ALACHUA, Fla. and TAMPA, Fla., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it will report 2025 third quarter financial results on Wednesday, October 29, 2025, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release. Investors interested in participating in the con ...
2 Unstoppable Growth Stocks to Buy During a Market Crash
The Motley Fool· 2025-10-15 08:33
Here are two smart ways to prepare for the next market downturn.President Trump recently reminded investors that it doesn't take much to send a buoyant stock market reeling. When the market opened on Friday, Oct. 10, 2025, the Nasdaq Composite (^IXIC -0.76%) index traded above $23,100 for the first time.On Oct. 10, at 10:57 am ET, President Trump commented that China was increasingly hostile regarding the rare earth metals it refines. In response, his administration is considering a massive increase in tari ...
Zynex Announces Appointment of Bret Wise to Board of Directors as Audit Committee Chair
Prnewswire· 2025-10-14 22:07
, /PRNewswire/ --Â Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the appointment of Bret Wise to its Board of Directors. Mr. Wise will also serve as Chair of the Audit Committee. "Bret Wise is a great addition to our Board of Directors as the Chair of our Audit Committee as we continue to refocus the Zynex mission and vision around patie ...
Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma
Globenewswire· 2025-10-14 20:40
AUDUBON, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, has announced the launch of the ANTHEM™ Elbow Fracture System, a fully comprehensive plating portfolio designed to address a wide spectrum of elbow fractures. The ANTHEM™ Elbow Fracture System is designed to offer surgeons anatomically contoured plates to treat a variety of fractures, regardless of severity or complexity, with a simplified workflow. Engineered to simplify surgical ...
WORK Medical Technology Group LTD Announces Receipt of Delisting Determination Letter from Nasdaq
Globenewswire· 2025-10-14 20:10
Hangzhou, China, Oct. 14, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) Medical Treatment Equipment Co., Ltd. and its subsidiaries in China, today announced that the Company received a determination letter, dated October 9, 2025 (the “Letter”), from the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company of Nasdaq’s deter ...
Elutia to Present at the LD Micro Main Event XIX Conference on Tuesday, October 21
Globenewswire· 2025-10-14 20:05
GAITHERSBURG, Md., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, President and Chief Executive Officer, will present at the LD Micro Main Event XIX Conference in San Diego on Tuesday, October 21, 2025, at 1:00 p.m. PT (4:00 p.m. ET). LD Micro Main Event XIX ConferencePresentation Date: Tuesday, October 21, 2025Presentation Time: 1:00 p.m. PT (4:00 p.m. ET)Webcast: Click here Elutia management w ...
TransMedics Group Stock Earns Relative Strength Rating Upgrade
Investors· 2025-10-14 19:23
TRUMP MARKET MOVES: Will These Be Next U.S. Equity Stakes? On Tuesday, TransMedics Group (TMDX) stock earned an upgrade to its Relative Strength (RS) Rating, from 69 to 73. Â Can You Really Time The Stock Market? This proprietary rating tracks technical performance by showing how a stock's price action over the last 52 weeks measures up against that of the other stocks in our database. Over 100 years of… IBD Videos Get market updates, educational videos, webinars, and stock analysis. Get Started Related new ...
Johnson & Johnson’s (JNJ) Strong Dividend Track Record and Focus on Innovation
Yahoo Finance· 2025-10-14 18:41
Johnson & Johnson (NYSE:JNJ) is included among the 12 Reliable Dividend Stocks for Maximum Income. Johnson & Johnson’s (JNJ) Strong Dividend Track Record and Focus on Innovation Johnson & Johnson (NYSE:JNJ) operates as a global healthcare lea‍de‌r, focusing p‌rimari​ly on pharmaceuticals and medi⁠cal d‍evices. Its⁠ operations are di‍vided into two main se⁠gment​s: Innovative Me⁠dicine, which de⁠velops and markets prescription drugs, and MedTech, which produces medi⁠cal d‌evic‌es. Up until 2023, Johnson ...
Edwards Lifesciences: Inflection Incoming, But When? (NYSE:EW)
Seeking Alpha· 2025-10-14 18:36
Edwards Lifesciences Corporation (NYSE: EW ) was founded in 1958 and is based in Irvine, CA. It is a leader in designing and commercializing innovative technologies for the treatment of advanced cardiovascular diseases. Its main productsI have been investing in the stock market since I was 17 years old, and over the 25+ years since I have learned the joy of compounding, the value of dividend reinvesting, and the principle that patient investing through good times and bad brings the greatest rewards. I belie ...